PolicyBrief
H.R. 3674
119th CongressJun 3rd 2025
Global Alzheimer’s Initiative Now Act
IN COMMITTEE

The Global Alzheimer’s Initiative Now Act authorizes U.S. participation in the Davos Alzheimer's Collaborative to accelerate global efforts in preventing, diagnosing, and treating Alzheimer's and dementia, contingent upon securing matching international funds.

Ami Bera
D

Ami Bera

Representative

CA-6

LEGISLATION

New Bill Pushes US to Lead Global Alzheimer's Fight, Caps Funding at 33% of International Effort

This new piece of legislation, the Global Alzheimer’s Initiative Now Act, is essentially the U.S. government deciding to put its money where its mouth is regarding the global fight against Alzheimer’s and dementia. The bill starts by laying out some pretty stark facts: globally, nearly 60 million people currently have these conditions, and that number is projected to hit 150 million by 2050. That’s more than cancer and HIV combined, and it’s expected to cost the global economy over $1.3 trillion annually, with costs doubling every decade. The policy established in this bill is straightforward: the U.S. will take a leadership role in international collaboration, focusing especially on low- and middle-income countries where cases are rising fastest.

The Global Health Cost Crisis

If you’re juggling rising costs, this bill explains why this matters to your wallet, even if the disease hasn't hit your family yet. The bill notes that by 2050, the ratio of working-age people supporting older people is projected to more than double in most countries. This demographic shift puts immense pressure on social systems, healthcare, and national budgets—costs that inevitably filter down to taxpayers and employers. This bill is an attempt to get ahead of that curve by speeding up research and treatment globally, which theoretically lowers the long-term strain on everyone. It also highlights that women are disproportionately affected, both as patients and as caregivers, providing about 70% of all care hours.

Putting Skin in the Game: The Davos Collaborative

The core of the Act is authorizing the U.S. to officially join and contribute funds to the Davos Alzheimer’s Collaborative (DAC). This is a group dedicated to accelerating global research, prevention, and care. Think of it as the U.S. buying a seat at the table where international solutions are being hammered out. The President gets to pick an experienced public health and development expert to represent the U.S. on DAC’s Advisory Council and potentially its Board, ensuring our interests and expertise are included in the global strategy.

Fiscal Firewalls and Matching Funds

Here’s the part that shows the bill’s commitment to fiscal responsibility and leveraging foreign aid: the U.S. contribution to DAC is capped, and it’s not a blank check. Specifically, the bill states that U.S. funding can only be spent if DAC first secures funding from other, non-U.S. sources. Furthermore, between fiscal years 2026 and 2030, the total U.S. contribution cannot exceed 33% of all money DAC receives from all sources combined. This is a smart safeguard, ensuring that U.S. taxpayer dollars are matched by other countries and private donors, maximizing the impact of our spending. This means for every dollar the U.S. puts in, the rest of the world has to put in at least two, a solid way to share the financial burden of a global problem. The President must also report annually to Congress on how the money is being used and how DAC’s work aligns with U.S. global health strategies.